Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline

Author:

Landier Wendy1,Bhatia Smita1,Eshelman Debra A.1,Forte Katherine J.1,Sweeney Teresa1,Hester Allison L.1,Darling Joan1,Armstrong F. Daniel1,Blatt Julie1,Constine Louis S.1,Freeman Carolyn R.1,Friedman Debra L.1,Green Daniel M.1,Marina Neyssa1,Meadows Anna T.1,Neglia Joseph P.1,Oeffinger Kevin C.1,Robison Leslie L.1,Ruccione Kathleen S.1,Sklar Charles A.1,Hudson Melissa M.1

Affiliation:

1. From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric...

Abstract

The Children’s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers are risk-based, exposure-related clinical practice guidelines intended to promote earlier detection of and intervention for complications that may potentially arise as a result of treatment for pediatric malignancies. Developed through the collaborative efforts of the Children’s Oncology Group Late Effects Committee, Nursing Discipline, and Patient Advocacy Committee, these guidelines represent a statement of consensus from a multidisciplinary panel of experts in the late effects of pediatric cancer treatment. The guidelines are both evidence-based (utilizing established associations between therapeutic exposures and late effects to identify high-risk categories) and grounded in the collective clinical experience of experts (matching the magnitude of risk with the intensity of screening recommendations). They are intended for use beginning 2 or more years following the completion of cancer therapy; however, they are not intended to provide guidance for follow-up of the survivor’s primary disease. A complementary set of patient education materials (“Health Links”) was developed to enhance follow-up care and broaden the application of the guidelines. The information provided in these guidelines is important for health care providers in the fields of pediatrics, oncology, internal medicine, family practice, and gynecology, as well as subspecialists in many fields. Implementation of these guidelines is intended to increase awareness of potential late effects and to standardize and enhance follow-up care provided to survivors of pediatric cancer throughout the lifespan. The Guidelines, and related Health Links, can be downloaded in their entirety at www.survivorshipguidelines.org .

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Reference49 articles.

1. Cancer Survivorship Research: Challenge and Opportunity

2. Annual Report to the Nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden

3. Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting

4. von der Weid N: Late effects in long-term survivors of ALL in childhood: Experiences from the SPOG late effects study. Swiss Med Wkly 131:180,2001-187,

5. Garre ML, Gandus S, Cesana B, et al: Health status of long-term survivors after cancer in childhood. Results of an uniinstitutional study in Italy. Am J Pediatr Hematol Oncol 16:143,1994-152,

Cited by 618 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3